Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established substantial manufacturing facilities focusing on this essential antiviral medicine . Identifying the precise top manufacturers can be complex due to fluctuating market dynamics, but reputable nam